Metuchen Pharms Drug Patent Portfolio
Metuchen Pharms owns 1 orange book drug protected by 2 US patents Given below is the list of Metuchen Pharms's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6656935 | Aromatic nitrogen-containing 6-membered cyclic compounds | 27 Apr, 2025 | Expired |
| US7501409 | Preparations for oral administration | 05 May, 2023 | Expired |
Latest Legal Activities on Metuchen Pharms's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Metuchen Pharms.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 12th Year, Large Entity | 27 Aug, 2020 | US7501409 (Litigated) |
|
Patent Term Extension Certificate
Critical
| 18 Mar, 2016 | US6656935 (Litigated) |
| Notice of Final Determination -Eligible | 18 Nov, 2015 | US6656935 (Litigated) |
|
FDA Final Eligibility Letter
Critical
| 21 Jan, 2015 | US6656935 (Litigated) |
| transaction for FDA Determination of Regulatory Review Period | 10 Jun, 2014 | US6656935 (Litigated) |
| transaction for FDA Determination of Regulatory Review Period | 09 May, 2014 | US6656935 (Litigated) |
| Second letter to regulating agency to determine regulatory review period | 19 Mar, 2014 | US6656935 (Litigated) |
| Letter from FDA or Dept of Agriculture re PTE application | 13 Feb, 2013 | US6656935 (Litigated) |
| Initial letter Re: PTE Application to regulating agency | 28 Sep, 2012 | US6656935 (Litigated) |
| Patent Term Extension Application under 35 USC 156 Filed | 18 Jun, 2012 | US6656935 (Litigated) |
|
Patent Issue Date Used in PTA Calculation
Critical
| 10 Mar, 2009 | US7501409 (Litigated) |
|
Recordation of Patent Grant Mailed
Critical
| 10 Mar, 2009 | US7501409 (Litigated) |
|
Email Notification
Critical
| 19 Feb, 2009 | US7501409 (Litigated) |
|
Issue Notification Mailed
Critical
| 18 Feb, 2009 | US7501409 (Litigated) |
|
Application Is Considered Ready for Issue
Critical
| 02 Feb, 2009 | US7501409 (Litigated) |
Metuchen Pharms's Family Patents
Metuchen Pharms Drug List
Given below is the complete list of Metuchen Pharms's drugs and the patents protecting them.
1. Stendra
Stendra is protected by 2 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6656935 | Aromatic nitrogen-containing 6-membered cyclic compounds |
27 Apr, 2025
(2 months ago)
| Expired |
| US7501409 | Preparations for oral administration |
05 May, 2023
(2 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Stendra's drug page